New $8.6M NIH RC2 Grant for an Interdisciplinary Team of ISCRM Faculty.
October 6, 2025 | Categories: Award, Core Faculty |An interdisciplinary team of ISCRM researchers has received an $8.6 million grant from the NIH to accelerate cell therapies for diabetes by achieving more reliable and reproducible generation of fully functional pancreatic islets from multiple stem cell lines. Read More about New $8.6M NIH RC2 Grant for an Interdisciplinary Team of ISCRM Faculty.
Laura Crisa and Farid Moussavi-Harami Receive Tietze Awards
June 3, 2022 | Categories: Award, Core Faculty |Laura Crisa, MD, PhD and Farid Moussavi-Harami, MD have received prestigious awards from the John H. Tietze Foundation Trust that will help fuel promising research underway in their labs. Read More about Laura Crisa and Farid Moussavi-Harami Receive Tietze Awards
Improving Islet Transplantation to Treat Type 1 Diabetes
June 22, 2020 | Categories: Award |A major grant from the NIH will allow three ISCRM investigators to use their combined expertise in islet and stem cell biology, vascular biology and cellular immunology, and biomaterials to significantly improve the wellbeing of people with type 1 diabetes. Read More about Improving Islet Transplantation to Treat Type 1 Diabetes
Improved Method for Converting Stem Cells into Pancreatic Islet Progenitor Cells Detailed in iScience
August 29, 2019 | Categories: Announcements, Core Faculty, Research |Type 1 diabetes is a disease that occurs when the immune system attacks and kills the cells that produce insulin in the pancreas, known as beta-cells. Read More about Improved Method for Converting Stem Cells into Pancreatic Islet Progenitor Cells Detailed in iScience
